Table 2 Lymph-node status of the 175 study participants in relation to levels of PIK3CA-, PTEN mRNA expression and PIK3CA mutations in the primary breast carcinoma
PIK3CA expression | PTEN expression | PIK3CA mutations | ||||
|---|---|---|---|---|---|---|
Low PIK3CA | High PIK3CA | Low PTEN | High PTEN | Wildtype | Mutations | |
Number, N (%) | 87 (50) | 88 (50) | 87 (50) | 88 (50) | 107 (61) | 68 (39) |
Lymph node status, N (%) | ||||||
No metastases | 36 (41) | 34 (39) | 38 (44) | 32 (36) | 42 (39) | 28 (41) |
Metastases | 51 (59) | 54 (61) | 49 (56) | 56 (64) | 65 (61) | 40 (59) |
p = 0.71 | p = 0.32 | p = 0.80 | ||||